₹ 2,338.00
118.00 (5.32%)
L
Laurus Labs
₹ 2,338.00
Laurus Labs EPS Summary (consolidated)
The latest quarterly EPS of Laurus Labs as of Q2 Sep 2026 stands at ₹8.17. This is a 19.97% growth quarter on quarter and 126.32% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹6.59. It beat the estimate by ₹1.58. For the FY2026 the EPS of Laurus Labs stands at ₹16.47. This is a 147.67% growth compared with FY2025.
Laurus Labs EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

Z
Zydus Life Science

D
Dr Reddys Laboratories
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

